Eisai
4523.T
#2184
Rank
C$11.69 B
Marketcap
C$41.44
Share price
0.11%
Change (1 day)
0.14%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total debt

Total debt on the balance sheet as of September 2025 : C$2.21 Billion

According to Eisai's latest financial reports the company's total debt is C$2.21 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Eisai - Total debt on balance sheet (from 2009 to 2025)

Total debt by year

Year Total debt Change
2025-03-31C$1.80 B26.44%
2024-03-31C$1.42 B11.28%
2023-03-31C$1.27 B31.34%
2022-03-31C$0.97 B-4.48%
2021-03-31C$1.01 B-13.41%
2020-03-31C$1.17 B-29.49%
2019-03-31C$1.67 B-20.46%
2018-03-31C$2.09 B-17.76%
2017-03-31C$2.55 B8.59%
2016-03-31C$2.35 B-5.78%
2015-03-31C$2.49 B-5.73%
2014-03-31C$2.64 B-21.85%
2013-03-31C$3.38 B-18.59%
2012-03-31C$4.16 B-5.84%
2011-03-31C$4.41 B0.37%
2010-03-31C$4.40 B-18.11%
2009-03-31C$5.37 B31.03%
2008-03-31C$4.10 B176775.92%
2007-03-31C$2.31 M-43.76%
2006-03-31C$4.12 M-56.12%
2005-03-31C$9.39 M290.53%
2004-03-31C$2.4 M451.49%
2003-03-31C$0.43 M-99.44%
2002-03-31C$78.22 M-20.71%
2001-03-31C$98.65 M-60.62%
2000-03-31C$0.25 B